3. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A,
Castella M, Rio P, Sleep E, Gonzalez F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surralles J, Bueren J, Izpisua Belmonte JC. Disease-corrected haematopoietic
progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009; 460:
53-9.
4. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A,
Cooper O, Mitalipova M, Isacson O, Jaenisch R. Parkinson's disease patient-derived
induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009; 136:
964-77.
5. Eiges R, Urbach A, Malcov M, Frumkin T, Schwartz T, Amit A, Yaron Y, Eden A,
Yanuka O, Benvenisty N, Ben-Yosef D. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed
embryos. Cell Stem Cell. 2007; 1: 568-77.
6. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F,
Zhou Q. iPS cells produce viable mice through tetraploid complementation. Nature. 2009; 461: 86-90.
7.
8. Kang L, Wang J, Zhang Y, Kou Z, Gao S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell. 2009; 5: 135-8. Placantonakis DG, Tomishima MJ, Lafaille F, Desbordes SC, Jia F, Socci ND, Viale A,
Lee H, Harrison N, Tabar V, Studer L. BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage. Stem Cells. 2009; 27: 521-32.
9. Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, Katibah GE,
Amora R, Boydston EA, Zeitler B, Meng X, Miller JC, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009; 27: 851-7.
10. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S,
Baldwin KK. Adult mice generated from induced pluripotent stem cells. Nature. 2009;
461: 91-4.
11. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T,
Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature. 2010; 465: 175-81.
12. Kang L, Wu T, Tao Y, Yuan Y, He J, Zhang Y, Luo T, Kou Z, Gao S. Viable mice
produced from three-factor induced pluripotent stem (iPS) cells through tetraploid
complementation. Cell Res. 2011; 21: 546-9.
13. Liu L, Luo GZ, Yang W, Zhao X, Zheng Q, Lv Z, Li W, Wu HJ, Wang L, Wang XJ, Zhou
Q. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of
mouse stem cells. J Biol Chem. 2010; 285: 19483-90.
14.
15. Chin MH, Pellegrini M, Plath K, Lowry WE. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell. 2010; 7: 263-9. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC. Persistent donor cell gene
expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One. 2010; 5: e8975.
16. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R,
Young RA. Chromatin structure and gene expression programs of human embryonic